A detailed history of Jacobs & CO transactions in Merck & Co., Inc. stock. As of the latest transaction made, Jacobs & CO holds 108,890 shares of MRK stock, worth $10.5 Million. This represents 1.24% of its overall portfolio holdings.

Number of Shares
108,890
Previous 102,483 6.25%
Holding current value
$10.5 Million
Previous $12.7 Million 2.54%
% of portfolio
1.24%
Previous 1.33%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 01, 2024

BUY
$111.15 - $128.97 $712,138 - $826,310
6,407 Added 6.25%
108,890 $12.4 Million
Q2 2024

Jul 12, 2024

SELL
$123.8 - $132.96 $87,526 - $94,002
-707 Reduced 0.69%
102,483 $12.7 Million
Q1 2024

Apr 12, 2024

SELL
$113.24 - $131.95 $354,780 - $413,399
-3,133 Reduced 2.95%
103,190 $13.6 Million
Q4 2023

Jan 17, 2024

BUY
$100.18 - $109.02 $508,012 - $552,840
5,071 Added 5.01%
106,323 $11.6 Million
Q3 2023

Oct 13, 2023

BUY
$102.95 - $114.33 $133,629 - $148,400
1,298 Added 1.3%
101,252 $10.4 Million
Q2 2023

Jul 11, 2023

SELL
$108.61 - $118.38 $654,483 - $713,357
-6,026 Reduced 5.69%
99,954 $11.5 Million
Q1 2023

Apr 17, 2023

SELL
$102.94 - $114.86 $816,108 - $910,610
-7,928 Reduced 6.96%
105,980 $11.3 Million
Q4 2022

Jan 13, 2023

SELL
$87.44 - $112.11 $1.22 Million - $1.57 Million
-14,002 Reduced 10.95%
113,908 $12.6 Million
Q3 2022

Oct 11, 2022

SELL
$84.53 - $94.96 $126,625 - $142,250
-1,498 Reduced 1.16%
127,910 $11 Million
Q2 2022

Jul 19, 2022

SELL
$83.49 - $94.64 $891,756 - $1.01 Million
-10,681 Reduced 7.62%
129,408 $11.8 Million
Q1 2022

Apr 14, 2022

SELL
$73.51 - $82.4 $140,477 - $157,466
-1,911 Reduced 1.35%
140,089 $11.5 Million
Q4 2021

Jan 21, 2022

BUY
$72.28 - $90.54 $319,766 - $400,548
4,424 Added 3.22%
142,000 $10.9 Million
Q3 2021

Oct 13, 2021

BUY
$71.68 - $78.83 $623,759 - $685,978
8,702 Added 6.75%
137,576 $10.3 Million
Q2 2021

Jul 15, 2021

BUY
$70.31 - $77.77 $1.1 Million - $1.21 Million
15,617 Added 13.79%
128,874 $10 Million
Q1 2021

Apr 05, 2021

BUY
$68.86 - $81.11 $702,647 - $827,646
10,204 Added 9.9%
113,257 $8.73 Million
Q4 2020

Jan 12, 2021

BUY
$71.77 - $79.65 $740,522 - $821,828
10,318 Added 11.13%
103,053 $8.43 Million
Q3 2020

Dec 03, 2020

BUY
$73.18 - $82.95 $389,317 - $441,294
5,320 Added 6.09%
92,735 $7.69 Million
Q2 2020

Jul 09, 2020

BUY
$70.42 - $80.13 $639,695 - $727,900
9,084 Added 11.6%
87,415 $6.76 Million
Q1 2020

Apr 13, 2020

BUY
$63.36 - $87.82 $59,685 - $82,726
942 Added 1.22%
78,331 $6.03 Million
Q4 2019

Jan 29, 2020

BUY
$77.58 - $87.54 $514,200 - $580,215
6,628 Added 9.37%
77,389 $7.04 Million
Q3 2019

Nov 04, 2019

BUY
$76.08 - $82.93 $49,832 - $54,319
655 Added 0.93%
70,761 $5.96 Million
Q2 2019

Aug 01, 2019

BUY
$69.84 - $81.59 $1.8 Million - $2.1 Million
25,709 Added 57.91%
70,106 $5.88 Million
Q1 2019

Apr 29, 2019

BUY
$69.58 - $79.36 $3.09 Million - $3.52 Million
44,397 New
44,397 $3.69 Million

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $244B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Jacobs & CO Portfolio

Follow Jacobs & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jacobs & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jacobs & CO with notifications on news.